Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke

Tomáš Veverka, Petr Hluštík, Zuzana Tomášová, Pavel Hok, Pavel Otruba, Michal Král, Zbyněk Tüdös, Jana Zapletalová, Roman Herzig, Alois Krobot, Petr Kaňovský

. 2012 ; 319 (1-2) : 89-95.

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NS9920 MZ0 CEP Register

BACKGROUND: Investigations were performed to localize and analyze the botulinum toxin (BoNT-A) related changes of cerebral cortex activation in chronic stroke patients suffering from severe hand paralysis with arm spasticity. Effects on task- related cerebral activation were evaluated by functional magnetic resonance imaging (fMRI). METHODS: 14 patients (5 males, 9 females, mean age 55.3 years) suffering from upper limb post-stroke spasticity were investigated. The change of arm spasticity was assessed by using the modified Ashworth scale (MAS). FMRI sessions were performed before (W0), four weeks (W4) and 11 weeks (W11) after BoNT-A application. Patients were scanned while performing imaginary movement with the impaired hand. Group fMRI analysis included patient age as a covariate. RESULTS: BoNT-A treatment was effective in alleviation of arm spasticity. Mean MAS was at Week 0: 2.5 (SD 0.53), at Week 4: 1.45 (SD 0.38), at Week 11: 2.32 (SD 0.44). Task-related fMRI prior to the treatment showed extensive activation of bilateral frontoparietal sensorimotor cortical areas, anterior cingulate gyrus, pallidum, thalamus and cerebellum. Effective BoNT-A treatment (W4) resulted in partial reduction of active network volume in most of the observed areas, whereas BoNT-free data (W11) revealed further volume reduction in the sensorimotor network. On direct comparison, significant activation decreases associated with BoNT-A treatment were located in areas outside the classical sensorimotor system, namely, ipsilesional lateral occipital cortex, supramarginal gyrus and precuneus cortex. On comparison of W4 and W11, no activation increases were found, instead, activation further decreased in ipsilesional insular cortex, contralesional superior frontal gyrus and bilateral frontal pole. CONCLUSIONS: Whole brain activation patterns during BoNT-A treatment of post-stroke arm spasticity and further follow up document predominantly gradual changes both within and outside the classical sensorimotor system.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13012650
003      
CZ-PrNML
005      
20170727082949.0
007      
ta
008      
130404s2012 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jns.2012.05.008 $2 doi
035    __
$a (PubMed)22687958
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Veverka, Tomáš, $d 1976- $7 xx0215370 $u Department of Neurology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic. veverka.tomas@seznam.cz
245    10
$a BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke / $c Tomáš Veverka, Petr Hluštík, Zuzana Tomášová, Pavel Hok, Pavel Otruba, Michal Král, Zbyněk Tüdös, Jana Zapletalová, Roman Herzig, Alois Krobot, Petr Kaňovský
520    9_
$a BACKGROUND: Investigations were performed to localize and analyze the botulinum toxin (BoNT-A) related changes of cerebral cortex activation in chronic stroke patients suffering from severe hand paralysis with arm spasticity. Effects on task- related cerebral activation were evaluated by functional magnetic resonance imaging (fMRI). METHODS: 14 patients (5 males, 9 females, mean age 55.3 years) suffering from upper limb post-stroke spasticity were investigated. The change of arm spasticity was assessed by using the modified Ashworth scale (MAS). FMRI sessions were performed before (W0), four weeks (W4) and 11 weeks (W11) after BoNT-A application. Patients were scanned while performing imaginary movement with the impaired hand. Group fMRI analysis included patient age as a covariate. RESULTS: BoNT-A treatment was effective in alleviation of arm spasticity. Mean MAS was at Week 0: 2.5 (SD 0.53), at Week 4: 1.45 (SD 0.38), at Week 11: 2.32 (SD 0.44). Task-related fMRI prior to the treatment showed extensive activation of bilateral frontoparietal sensorimotor cortical areas, anterior cingulate gyrus, pallidum, thalamus and cerebellum. Effective BoNT-A treatment (W4) resulted in partial reduction of active network volume in most of the observed areas, whereas BoNT-free data (W11) revealed further volume reduction in the sensorimotor network. On direct comparison, significant activation decreases associated with BoNT-A treatment were located in areas outside the classical sensorimotor system, namely, ipsilesional lateral occipital cortex, supramarginal gyrus and precuneus cortex. On comparison of W4 and W11, no activation increases were found, instead, activation further decreased in ipsilesional insular cortex, contralesional superior frontal gyrus and bilateral frontal pole. CONCLUSIONS: Whole brain activation patterns during BoNT-A treatment of post-stroke arm spasticity and further follow up document predominantly gradual changes both within and outside the classical sensorimotor system.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a paže $x patofyziologie $7 D001132
650    _2
$a botulotoxiny typu A $x farmakologie $x terapeutické užití $7 D019274
650    _2
$a ischemie mozku $x komplikace $x patofyziologie $7 D002545
650    _2
$a mapování mozku $7 D001931
650    _2
$a mozková kůra $x účinky léků $x patofyziologie $7 D002540
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a svalová spasticita $x farmakoterapie $x etiologie $x patofyziologie $7 D009128
650    _2
$a nervosvalové látky $x farmakologie $x terapeutické užití $7 D009465
650    _2
$a paralýza $x farmakoterapie $x etiologie $x patofyziologie $7 D010243
650    _2
$a psychomotorický výkon $x účinky léků $x fyziologie $7 D011597
650    _2
$a cévní mozková příhoda $x komplikace $x patofyziologie $7 D020521
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hluštík, Petr $u Department of Neurology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic; Department of Radiology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
700    1_
$a Tomášová, Zuzana $u Department of Neurology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
700    1_
$a Hok, Pavel $u Department of Neurology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
700    1_
$a Otruba, Pavel $u Department of Neurology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
700    1_
$a Král, Michal $u Department of Neurology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
700    1_
$a Tüdös, Zbyněk $u Department of Radiology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
700    1_
$a Zapletalová, Jana $u Department of Biophysics, Biometry and Statistics, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
700    1_
$a Herzig, Roman $u Department of Neurology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
700    1_
$a Krobot, Alois $u Department of Physiotherapy, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
700    1_
$a Kaňovský, Petr $u Department of Neurology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
773    0_
$w MED00003004 $t Journal of the neurological sciences $x 1878-5883 $g Roč. 319, č. 1-2 (2012), s. 89-95
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22687958 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130404 $b ABA008
991    __
$a 20170727083451 $b ABA008
999    __
$a ok $b bmc $g 975848 $s 810931
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 319 $c 1-2 $d 89-95 $i 1878-5883 $m Journal of the neurological sciences $n J Neurol Sci $x MED00003004
GRA    __
$a NS9920 $p MZ0
LZP    __
$a Pubmed-20130404

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...